Evidence map›Paper›PMID 26116373›Full record

ArticleBMC public health2015

Population awareness of risks related to medicinal product use in Vientiane Capital, Lao PDR: a cross-sectional study for public health improvement in low and middle income countries.

Céline Caillet, Chanvilay Sichanh, Lamphone Syhakhang, Cyrille Delpierre, Chanthanom Manithip, Mayfong Mayxay, Maryse Lapeyre-Mestre, Paul N Newton, Anne Roussin

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Céline CailletFaculté de Médecine, Equipe de Pharmacoépidémiologie UMR 1027 INSERM-Université de Toulouse III, Service de Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire de Toulouse, 37 allées Jules Guesde, 31000, Toulouse, France. celine.caillet@univ-tlse3.fr.
Chanvilay SichanhWorldWide Antimalarial Resistance Network, University of Oxford, Wellington Square, OX1 2JD, Oxford, UK. singsing_chanvilay@yahoo.fr.
Lamphone SyhakhangFood and Drug Department, Ministry of Health, Simuang Road, Vientiane Capital, Lao People's Democratic Republic. syhakhangl@yahoo.com.
Cyrille DelpierreFaculté de Médecine, Cancer et maladies chroniques, UMR1027 INSERM- Université de Toulouse III, 37 Allées Jules Gusede, 31000, Toulouse, France. cyrildelpierre@yahoo.fr.
Chanthanom ManithipFaculty of Pharmacy, University of Health Sciences, P.O.Box 7444, Samsenthai Road, Vientiane, Lao People's Democratic Republic. manithipchanthanom@gmail.com.
Mayfong MayxayLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, FaNgum Rd, Vientiane, Lao People's Democratic Republic. mayfong@tropmedres.ac.
Maryse Lapeyre-MestreFaculté de Médecine, Equipe de Pharmacoépidémiologie UMR 1027 INSERM-Université de Toulouse III, Service de Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire de Toulouse, 37 allées Jules Guesde, 31000, Toulouse, France. maryse.lapeyre-mestre@univ-tlse3.fr.
Paul N NewtonWorldWide Antimalarial Resistance Network, University of Oxford, Wellington Square, OX1 2JD, Oxford, UK. paul@tropmedres.ac.
Anne RoussinFaculté de Médecine, Equipe de Pharmacoépidémiologie UMR 1027 INSERM-Université de Toulouse III, Service de Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire de Toulouse, 37 allées Jules Guesde, 31000, Toulouse, France. anne.roussin@univ-tlse3.fr.
Laboratoire Epidémiologie et Analyses en Santé Publique : Risques, Maladies Chroniques et Handicaps · FRMahosot Hospital · LAMinistry of Health · LAUniversity of Health Sciences Vientiane · LAUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile essential medicines have been made more available in all but the most remote areas in low and middle income countries (L/MICs) over the past years, inappropriate and incorrect use of good quality medicines remains a key impediment for public health. In addition, as medicines have a potential to cause harm (medicine risks), adequate awareness by medicine users of the risks of adverse reactions is essential, especially as self-medication is common in L/MICs. This study aimed to investigate the awareness of Lao residents regarding medicine risks in Vientiane Capital, Lao People's Democratic Republic.

methodsFace-to-face interviews using structured questionnaires of 144 residents older than 16 years were carried out in 12 randomly selected villages out of the 146 villages of Vientiane Capital with at least one health facility.

resultsThe respondents were mainly (85.0 %) the heads of households or their husband/spouse . The majority of the respondents were unaware (61.8 %) of medicine risks. Compared to residents living in the urban district of Xaysetha, living in peri-urban and even more in rural areas were identified as factors associated with being unaware of medicine risks [adjusted odds ratio (aOR) =3.3, 95 % Confidence Interval (CI) = 1.1-9.4]) and aOR =7.5 (95 % CI = 2.3-24.2), respectively]. In addition, more than half of the respondents had never heard of poor quality medicines, with a higher rate in rural/peri-urban compared to urban districts (55.6 % vs 38.9 %, respectively, p = 0.02). Finally, approximately one third of all respondents thought that traditional medicines could not cause harm.

conclusionsOverall, these results suggest a lack of awareness about medicinal product risks. Differences according to the place of residence are apparent and could be partly explained by a lower level of training of healthcare providers in contact with the population in the rural districts in particular. Communication on medicinal product risks to patients through well-trained healthcare providers could probably make a valuable contribution towards the appropriate use of medicines in L/MICs.

Indexed as

AwarenessHealth BehaviorAdultAgedCross-Sectional StudiesFemaleHealth StatusHumansLaosMaleMiddle AgedNonprescription DrugsOdds RatioRural PopulationSelf MedicationUrban PopulationNonprescription Drugs

Identifiers

PMID26116373
PMCPMC4483223
OpenAlexW1860450431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.